MALAT1 and breast cancer: In BC patients, MALAT1 is considered a possible indicator for early prognosis and diagnosis, as its expression is seen to be upregulated in such patients with downregulation of its expression in patients receiving breast-conserving surgery in combination with chemotherapy [187,188].